Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
NPJ Breast Cancer|March 15, 2026
HIF-1-regulated TPM3 links hypoxia to motility and invasion beyond the hypoxic fraction in triple-negative breast cancerChumin Zhou, Jack T Crusher, Kate Friesen, et al.
Future Oncology (London, England)|January 16, 2025
Open-label, phase Ia study of STING agonist BI 1703880 plus ezabenlimab for patients with advanced solid tumorsKevin Harrington, Shigehisa Kitano, Valentina Gambardella, et al.
Journal of Immunotherapy and Precision Oncology|December 8, 2025
Replication-Competent, Tumor-Specific Immuno-Gene Vectors Allow for Exchange of Transgenes and Lead to Viral Persistence Following IV AdministrationLee S Rosen, Christian Ottensmeier, Maria Hawkins, et al.
British Journal of Cancer|October 26, 2020
Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancerFrances Willenbrock, Catrin M Cox, Eileen E Parkes, et al.
NPJ Breast Cancer|June 26, 2021
The clinical and molecular significance associated with STING signaling in breast cancerEileen E Parkes, Matthew P Humphries, Elaine Gilmore, et al.
Journal of the National Cancer Institute|October 7, 2016
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast CancerEileen E Parkes, Steven M Walker, Laura E Taggart, et al.
Journal of Oncology|January 18, 2019
Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast CancerMatthew P Humphries, Sean Hynes, Victoria Bingham, et al.
Scientific Reports|November 3, 2025
IGF-1 regulates cancer cell immune evasion in prostate cancerAshwin M Nandakumar, Alessandro Barberis, Jinseon Kim, et al.
The Lancet. Oncology|October 12, 2024
Validity and timeliness of cancer diagnosis data collected during a prospective cohort study and reported by the English and Welsh cancer registries: a retrospective, comparative analysisAshley Jackson, Pradeep S Virdee, Sharon Tonner, et al.
British Journal of Cancer|July 10, 2020
Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer modelYiannis Philippou, Hanna T Sjoberg, Emma Murphy, et al.
Pageof 4